FDA Inspection 1310128 — CABIO Biotech (Wuhan) Co., Ltd. Gedian Branch
The FDA completed an inspection of CABIO Biotech (Wuhan) Co., Ltd. Gedian Branch on Mar 18, 2026 in Ezhou. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 18, 2026
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Ezhou (China)